Dear MTCONS,
You are cordially invited to attend the MTCONS July 10, 2025 Chapter Meeting
The Topic is: EPKINLY (epcoritamab-bysp) Now Approved in 3L+ Follicular Lymphoma
Discussing efficacy and safety of a treatment for 3L+ DLBCL and 3L+ FL
The First-and-Only Subcutaneous Bispecific Antibody Approved In Both 3L+ DLBCL and 3L+ FL
PRESENTED BY:
Jonathan Abbas, MD
Director, Acute Leukemia Program
Tennessee Oncology
DATE/TIME:
Thursday, July 10, 2025Registration: 5:30 PM, Dinner and Presentation: 6:00 PM
LOCATION:
Halls Chophouse
1600 West End Ave
Nashville, TN 37203
